Synthetic Biology Market

Synthetic Biology Market Size by Technology (Gene Synthesis, Sequencing, Site-Directed Mutagenesis, Measurement and Modelling, Nanotechnology, Genome Engineering, Bioinformatics, Cloning, Microfluidics, NGS Technology, Bioprocessing, PCR Technology, and Others), Product Type (Synthetic DNA & Oligonucleotides, Software Tools, Chassis Organisms, Synthetic Genes, Synthetic Clones, and Synthetic Cells), Application, End User, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-13037
  • Published Date: Nov, 2022
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global synthetic biology market is expected to grow from USD 11.88 billion in 2022 to USD 55.71 billion by 2030, at a CAGR of 21.31% from 2022-2030. The Asia Pacific synthetic biology market is expected to grow the fastest during the forecast period.

Market Introduction:

The living organism in nature is a biological being that has evolved through the ages to adapt to the existing environment. Nature is balanced so that every problem in nature already has a solution. Synthetic biology is a branch of natural sciences which revolves around redesigning organisms found in nature or systems found in nature to solve everyday medical or other anthropological problems. Synthetic biology takes elements from nature and tweaks them using technology and human skill to deliver the desired result. The redesigning of organisms can be established by injecting them with new abilities or mitigating their weaknesses. Synthetic biology can potentially reform the world of medicine, manufacturing and agriculture. Genetically modified seeds that are resistant towards extreme weather conditions, weeds and pests are the most common applications of synthetic biology. Synthetic biology is also used to make green chemicals from agricultural waste. Production of microorganisms to clean air, water and land of pollutants is coming of age application utilized as a mitigating measure towards environmental conservation. Similar applications that can harness technological advancements to create green substitutes for harmful chemicals can pave the way for global sustainable development.

Synthetic Biology Market Size

Get an overview of this study by requesting a free sample

Recent Development

November 2022 - Researchers have discovered a method that may aid in optimizing the creation of monoclonal antibodies and other valuable proteins. The amount of a specific protein generated in mammalian cells may now be precisely controlled by MIT researchers using a method based on CRISPR proteins. This method is fine-tuned by synthesizing helpful proteins, such as the monoclonal antibodies used to cure cancer and other disorders or other cellular behaviours. The researchers demonstrated in their most recent study, which was published in Nature Communications that this mechanism may function in many mammalian cells with remarkably consistent outcomes.

October 2022 – eureKARE, a pioneering company devoted to funding and establishing next-generation biotechnology businesses in the disruptive fields of synthetic biology, conducted its annual SynBio Day on October 13-14. Following the success of the first SynBio Day in 2021, the second SynBio Day in 2022 brought together scientists, business partners, government officials, and investors to discuss the opportunities and difficulties of using synthetic biology to combat climate change and improve the environment. A wide range of environmental challenges is being researched using synthetic biology, including developing environmentally friendly products like biofuels to reduce global emissions. Also, the development of bioplastics to replace plastic in furniture and packaging and the engineering of bacteria to break down synthetic materials could help reduce the more than 165 million tonnes of plastic that have polluted the oceans.

Market Dynamics:

Drivers:

The increasing scope of applications of synthetic biotechnology – The covid-19 pandemic increased the use of synthetic biology in developing testing kits, drugs, therapies, vaccines and other medications against coronavirus. Similarly, the increasing instances of extreme weather events destroying crops have developed a need to use synthetic biology to develop more climate-resilient crops. The rising threat of pathogens, pollution and climate change crisis has increased the funding for research and development in synthetic biology. The capital increase is being utilized to study the potential use of synthetic biotechnology in medicine, agriculture and life sciences, industrial applications like biofuels, green chemicals and other energy applications. The potential of synthetic biology to replicate the properties of essential chemicals and materials without their environmental effects has increased their adoption in several industries intending to reduce their carbon footprints to avoid further global temperature rise. Therefore, the rising research and development in synthetic biology are widening the scope of its applications which will drive the market.

Restraints:

Ethical concerns – The exact cause of coronavirus is not yet determined. However, the virus leaking from a research laboratory is one of the possible causes listed by several medical organizations. Since synthetic biology uses organisms from nature, including microorganisms, there is a high risk of these genetically altered or modified organisms leaking into the environment and causing devastation. They can mutate and infect humans or cause environmental damage or destruction. The over-exploitation of synthetic biology needs to be checked with proper regulatory measures in place. However, the lack of knowledge, regulation and international cooperation regarding the field of synthetic will lead to abuse of its applications which will have long-term impacts on mankind and the earth. Scientific communities and a few international groups are aware of these consequences. They have funded projects that look into the ethical aspect of the synthetic biology sector, which will limit the market's growth.

Opportunities:

Growing climate concern The overexploitation of natural resources, especially fossil fuels, has led to their scarcity in the contemporary world. Overusing these fossil fuels has released carbon emissions beyond nature's absorption capacity. The disbalance has caused the global temperature to rise, leading to catastrophic consequences that the population is witnessing now in the form of heatwaves, storms and floods. A significant contributor to the climate change crisis is the conventional petroleum or crude oil and gas used in almost every economy. Therefore, a flurry of investments and initiatives to develop biofuels as an alternative is being seen globally to avert further environmental degradation. The global synthetic biology market will witness lucrative growth prospects in the future, given the increasing demand for biofuels.

Challenges:

Lack of infrastructure – The synthetic biology sector is thriving in high-income economies where the extensive capital required for the research and development of biofuels, biochemicals and other materials is provided through public and private investment. However, the low-and-middle-income countries lack the infrastructure to research synthetic biology's potential applications. The lack of infrastructure increases the risk of releasing pathogens or harmful organisms into the environment. The increasingly low funding for research and development discourages the youth from pursuing a scientific career, further dwindling the country's chances of pioneering a life sciences field. Therefore, the lack of infrastructure will challenge the market's growth.

Segmentation analysis:

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the most significant global synthetic biology market, with a 44.39% market revenue share in 2022. The presence of significant market players in the region contributes to the region's dominance. The well-established big-pharma giants with deep pockets invest extensively in research and development to exploit the potential applications of synthetic biology. The high number of research and academic institutes also aids the market's growth. Government assistance to these research and academic institutes also facilitates the advancement of the synthetic biology sector. The increasing government healthcare expenditure also furthers the market. The favourable government policies regarding the regulations and approvals of medicine, chemicals and other substances based on synthetic biology aid the market’s development.

North America Synthetic Biology Market Share in 2022- 44.39%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Technology segment analysis 

The technology segment is divided into gene synthesis, sequencing, site-directed mutagenesis, measurement and modelling, nanotechnology, genome engineering, bioinformatics, cloning, microfluidics, NGS technology, bioprocessing, PCR technology, and others. The PCR technology segment dominated the market with a revenue share of around 37% in 2022. PCR technology stands for polymerase chain reaction technology. PCR technology makes millions of DNA copies from a very small sample. The technique is highly effective in cloning or modifying gene fragments. It finds multiple applications in the field of synthetic biology. It is used as a diagnostic test for microorganisms, making their study and genotyping easier. 

Product type segment analysis

The product type is divided into synthetic DNA & oligonucleotides, software tools, chassis organisms, synthetic genes, synthetic clones, and synthetic cells. The synthetic DNA & oligonucleotides segment dominated the market with a market share of around 39% in 2022. The innovation of synthetic DNA drove the scope of applications of synthetic biology. Synthetic DNA & oligonucleotides are used where it is not possible or not desired to extract and use natural DNA. Such advanced technology enables scientists to research and develop new technologies by removing natural DNA's limitations. The flexibility synthetic DNA and oligonucleotides offer is the primary reason for its growing dominance in the segment.

Application segment analysis

The application is divided into healthcare and non-healthcare. The healthcare segment dominated the market with a market share of around 59% in 2022. The primary synthetic biology applications were in the healthcare sector in the form of diagnostic tests, DNA engineering, DNA synthesis and modification. The use of synthetic biotechnology to develop novel drugs, systems, and therapeutics to treat several acute and chronic diseases was the primary focus of the field pioneers. Therefore, the majority share of the applications belongs to the healthcare sector of the segment.

End-user segment analysis

The end user is divided into biotechnology & pharmaceutical companies and academic & government research institutes. The biotechnology & pharmaceutical companies segment dominated the market with a market share of around 55% in 2022. The increasing incidence of infectious, acute and other chronic diseases has developed a vast consumer market for biotechnology & pharmaceutical companies. The companies have increased their synthetic biology research to exploit the growing consumer market by exploiting the field for providing novel medicines and other therapeutics to treat several diseases and conditions. Furthermore, biotechnology and pharmaceutical companies have the capital to undertake such research. These companies can bring on the best technology, devices and personnel to develop the synthetic biology field.

Some of the Key Market Players:

  • Bota Biosciences Inc.
  • Creative Enzymes
  • Eurofins Scientific
  • Illumina Inc.
  • Integrated DNA Technologies
  • Merck
  • Novozymes
  • Origene Technologies
  • Pareto Biotechnologies
  • Thermos Fisher Scientific Inc.

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 11.88 Billion
Market size value in 2030 USD 55.71 Billion
CAGR (2022 to 2030) 21.31%
Historical data 2019-2020
Base Year 2021
Forecast 2022-2030
Segments The research segment is based on technology, product type, application, and end user.
Regional Segments The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the synthetic biology market was valued at USD 11.88 billion in 2022 to USD 55.71 billion by 2030.

The global synthetic biology market is growing at a CAGR of 21.31% during the forecast period 2022-2030.

The North American region emerged as the largest market for the synthetic biology.

The increasing scope of applications of synthetic biotechnology will influence the market's growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Technology
          4.3.2. Market Attractiveness Analysis by Product Type
          4.3.3. Market Attractiveness Analysis by Application
          4.3.4. Market Attractiveness Analysis by End User
          4.3.5. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing scope of applications of synthetic biotechnology
    5.3. Restraints
          5.3.1. Ethical concerns
    5.4. Opportunities
          5.4.1. Growing climate concern
    5.5. Challenges
          5.5.1. Lack of infrastructure

6. Global Synthetic Biology Market Analysis and Forecast, By Technology
    6.1. Segment Overview
    6.2. Gene Synthesis
    6.3. Sequencing
    6.4. Site-Directed Mutagenesis
    6.5. Measurement and Modelling
    6.6. Nanotechnology
    6.7. Genome Engineering
    6.8. Bioinformatics
    6.9. Cloning
    6.10. Microfluidics
    6.11. NGS Technology
    6.12. Bioprocessing
    6.13. PCR Technology
    6.14. Others

7. Global Synthetic Biology Market Analysis and Forecast, By Product Type
    7.1. Segment Overview
    7.2. Synthetic DNA & Oligonucleotides
    7.3. Software Tools
    7.4. Chassis Organisms
    7.5. Synthetic Genes
    7.6. Synthetic Clones
    7.7. Synthetic Cells

8. Global Synthetic Biology Market Analysis and Forecast, By Application
    8.1. Segment Overview
    8.2. Healthcare
    8.3. Non-Healthcare

9. Global Synthetic Biology Market Analysis and Forecast, By End User
    9.1. Segment Overview
    9.2. Biotechnology & Pharmaceutical Companies
    9.3. Academic & Government Research Institutes

10. Global Synthetic Biology Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Synthetic Biology Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in the Synthetic Biology Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Bota Biosciences Inc.
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Creative Enzymes
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Eurofins Scientific
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. Illumina Inc.
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Integrated DNA Technologies
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Merck
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Novozymes
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. Origene Technologies
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Pareto Biotechnologies
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. Thermos Fisher Scientific Inc.
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis
 

List of Table

1. Global Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

2. Global Gene Synthesis Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

3. Global Sequencing Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

4. Global Site-Directed Mutagenesis Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

5. Global Measurement and Modelling Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

6. Global Nanotechnology Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

7. Global Genome Engineering Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

8. Global Bioinformatics Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

9. Global Cloning Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

10. Global Microfluidics Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

11. Global NGS Technology Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

12. Global Bioprocessing Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

13. Global PCR Technology Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

14. Global Others Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

15. Global Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

16. Global Synthetic DNA & Oligonucleotides Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

17. Global Software Tools Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

18. Global Chassis Organisms Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

19. Global Synthetic Genes Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

20. Global Synthetic Clones Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

21. Global Synthetic Cells Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

22. Global Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

23. Global Healthcare Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

24. Global Non-Healthcare Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

25. Global Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

26. Global Biotechnology & Pharmaceutical Companies Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

27. Global Academic & Government Research Institutes Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

28. Global Synthetic Biology Market, By Region, 2019-2030 (USD Billion) 

29. North America Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

30. North America Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

31. North America Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

32. North America Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

33. U.S. Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

34. U.S. Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

35. U.S. Synthetic Biology Market, By Application, 2019-2030 (USD Billion)

36. U.S. Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

37. Canada Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

38. Canada Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

39. Canada Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

40. Canada Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

41. Mexico Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

42. Mexico Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

43. Mexico Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

44. Mexico Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

45. Europe Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

46. Europe Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

47. Europe Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

48. Europe Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

49. Germany Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

50. Germany Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

51. Germany Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

52. Germany Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

53. France Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

54. France Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

55. France Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

56. France Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

57. U.K. Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

58. U.K. Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

59. U.K. Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

60. U.K. Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

61. Italy Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

62. Italy Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

63. Italy Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

64. Italy Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

65. Spain Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

66. Spain Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

67. Spain Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

68. Spain Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

69. Asia Pacific Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

70. Asia Pacific Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

71. Asia Pacific Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

72. Asia Pacific Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

73. Japan Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

74. Japan Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion)

75. Japan Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

76. Japan Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

77. China Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

78. China Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

79. China Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

80. China Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

81. India Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

82. India Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

83. India Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

84. India Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

85. South America Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

86. South America Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

87. South America Synthetic Biology Market, By Application, 2019-2030 (USD Billion)

88. South America Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

89. Brazil Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

90. Brazil Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

91. Brazil Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

92. Brazil Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

93. Middle East and Africa Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

94. Middle East and Africa Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

95. Middle East and Africa Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

96. Middle East and Africa Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

97. UAE Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

98. UAE Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

99. UAE Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

100. UAE Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

101. South Africa Synthetic Biology Market, By Technology, 2019-2030 (USD Billion) 

102. South Africa Synthetic Biology Market, By Product Type, 2019-2030 (USD Billion) 

103. South Africa Synthetic Biology Market, By Application, 2019-2030 (USD Billion) 

104. South Africa Synthetic Biology Market, By End User, 2019-2030 (USD Billion) 

List of Figures 

1. Global Synthetic Biology Market Segmentation

2. Synthetic Biology Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Synthetic Biology Market Attractiveness Analysis by Technology

9. Global Synthetic Biology Market Attractiveness Analysis by Product Type

10. Global Synthetic Biology Market Attractiveness Analysis by Application

11. Global Synthetic Biology Market Attractiveness Analysis by End User

12. Global Synthetic Biology Market Attractiveness Analysis by Region

13. Global Synthetic Biology Market: Dynamics

14. Global Synthetic Biology Market Share by Technology (2022 & 2030)

15. Global Synthetic Biology Market Share by Product Type (2022 & 2030)

16. Global Synthetic Biology Market Share by Application (2022 & 2030)

17. Global Synthetic Biology Market Share by End User (2022 & 2030)

18. Global Synthetic Biology Market Share by Regions (2022 & 2030)

19. Global Synthetic Biology Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global synthetic biology market based on below-mentioned segments:

Global Synthetic Biology Market by Technology:

  • Gene Synthesis
  • Sequencing
  • Site-Directed Mutagenesis
  • Measurement and Modelling
  • Nanotechnology
  • Genome Engineering
  • Bioinformatics
  • Cloning
  • Microfluidics
  • NGS Technology
  • Bioprocessing
  • PCR Technology
  • Others

Global Synthetic Biology Market by Product Type:

  • Synthetic DNA & Oligonucleotides
  • Software Tools
  • Chassis Organisms
  • Synthetic Genes
  • Synthetic Clones
  • Synthetic Cells

Global Synthetic Biology Market by Application:

  • Healthcare
  • Non-Healthcare

Global Synthetic Biology Market by End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes

Global Synthetic Biology Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date